Update on statin therapyBALLANTYNE, Christie M.Cardiovascular reviews & reports. 2002, Vol 23, Num 1, pp 60-61, issn 0197-3118Article

A symposium: management summit on improving practice outcomeBALLANTYNE, Christie M.The American journal of cardiology. 2000, Vol 85, Num 3A, issn 0002-9149, 59 p.Conference Proceedings

Role of biomarkers in developing new therapies for vascular diseaseNAMBI, Vijay; BALLANTYNE, Christie M.World journal of surgery. 2007, Vol 31, Num 4, pp 676-681, issn 0364-2313, 6 p.Conference Paper

Combination therapy with statins and omega-3 fatty acidsNAMBI, Vijay; BALLANTYNE, Christie M.The American journal of cardiology. 2006, Vol 98, Num 4, issn 0002-9149, 34i-38i, SUPArticle

Role of lipid and lipoprotein profiles in risk assessment and therapyBALLANTYNE, Christie M; HOOGEVEEN, Ron C.The American heart journal. 2003, Vol 146, Num 2, pp 227-233, issn 0002-8703, 7 p.Article

Niacin Therapy: An Evolving Paradigm for the Management of Mixed Dyslipidemia and Low High-Density Lipoprotein CholesterolDAVIDSON, Michael H; BALLANTYNE, Christie M.The American journal of cardiology. 2008, Vol 101, Num 8A, issn 0002-9149, 64 p., SUPSerial Issue

Rationale and design of the Cardiac Hospitalization Atherosclerosis Management program at the University of California Los AngelesFONAROW, G. C; GAWLINSKI, A.The American journal of cardiology. 2000, Vol 85, Num 3A, pp 10A-17A, issn 0002-9149Conference Paper

Conditional risk factors for atherosclerosisKULLO, Iftikhar J; BALLANTYNE, Christie M.Mayo Clinic proceedings. 2005, Vol 80, Num 2, pp 219-230, issn 0025-6196, 12 p.Article

Fluvastatin: Clinical and safety profileCORSINI, Alberto; JACOBSON, Terry A; BALLANTYNE, Christie M et al.Drugs (Basel). 2004, Vol 64, Num 12, pp 1305-1323, issn 0012-6667, 19 p.Article

Achieving greater reductions in cardiovascular risk: Lessons from statin therapy on risk measures and risk reductionBALLANTYNE, Christie M.The American heart journal. 2004, Vol 148, Num 1, pp 3-8, issn 0002-8703, 6 p., SUPConference Paper

Lipids and CVD management : towards a global consensusBALLANTYNE, Christie; ARROLL, Bruce; SHEPHERD, James et al.European heart journal. 2005, Vol 26, Num 21, pp 2224-2231, issn 0195-668X, 8 p.Article

Newer risk markers and surrogate endpoints in atherosclerosis managementBALLANTYNE, Christie M.Clinical cardiology. Supplement (Mahwah, NJ). 2001, Vol 24, Num 8, pp III.13-III.17, SUP3Article

Cholesterol management in the era of managed careGRUNDY, S. M.The American journal of cardiology. 2000, Vol 85, Num 3A, pp 3A-9A, issn 0002-9149Conference Paper

Safety of Niacin and Simvastatin Combination TherapyBAYS, Harold.The American journal of cardiology. 2008, Vol 101, Num 8A, issn 0002-9149, 3B-8B, SUPArticle

Rationale for targeting multiple lipid pathways for optimal cardiovascular risk reductionBALLANTYNE, Christie M.The American journal of cardiology. 2005, Vol 96, Num 9A, pp 14K-19K, issn 0002-9149, SUPConference Paper

Efficacy and safety of an extended-release formulation of fluvastatin for once-daily treatment of primary hypercholesterolemiaBALLANTYNE, Christie M; MCKENNEY, James; TRIPPE, Bruce S et al.The American journal of cardiology. 2000, Vol 86, Num 7, pp 759-763, issn 0002-9149Article

Efficacy and safety of rosuvastatin alone and in combination with cholestyramine in Patients with severe hypercholesterolemia: A randomized, open-label, multicenter trialBALLANTYNE, Christie M; MILLER, Elinor; CHITRA, Rohini et al.Clinical therapeutics. 2004, Vol 26, Num 11, pp 1855-1864, issn 0149-2918, 10 p.Article

Current and future aims of lipid-lowering therapy: Changing paradigms and lessons from the Heart Protection Study on standards of efficacy and safetyBALLANTYNE, Christie M.The American journal of cardiology. 2003, Vol 92, Num 4B, pp 3K-9K, issn 0002-9149Conference Paper

Management of metabolic syndrome: statinsXYDAKIS, Antonios M; BALLANTYNE, Christie M.Endocrinology and metabolism clinics of North America. 2004, Vol 33, Num 3, issn 0889-8529, vi, 509-523 [16 p.]Article

Combination therapy for combined dyslipidemiaXYDAKIS, Antonios M; BALLANTYNE, Christie M.The American journal of cardiology. 2002, Vol 90, Num 10B, pp 21K-29K, issn 0002-9149Conference Paper

Icosapent ethyl for the treatment of hypertriglyceridemiaBALLANTYNE, Christie M; BRAECKMAN, Rene A; SONI, Paresh N et al.Expert opinion on pharmacotherapy. 2013, Vol 14, Num 10, pp 1409-1416, issn 1465-6566, 8 p.Article

Treating mixed dyslipidemias : Why and howBALLANTYNE, Christie M.Clinical cardiology. Supplement (Mahwah, NJ). 2001, Vol 24, Num 7, pp II.6-II9, SUP2Article

Lipid management in a private cardiology practice (The Midwest Heart experience)BROWN, A. S; COFER, L. A.The American journal of cardiology. 2000, Vol 85, Num 3A, pp 18A-22A, issn 0002-9149Conference Paper

Quality assessment and lipid management : Considerations for computer databases for tracking patientsSHORT, B. C; BALLANTYNE, C. M.The American journal of cardiology. 2000, Vol 85, Num 3A, pp 52A-56A, issn 0002-9149Conference Paper

Evidence to Support Aggressive Management of High-Density Lipoprotein Cholesterol : Implications of Recent Imaging TrialsTAYLOR, Alien J.The American journal of cardiology. 2008, Vol 101, Num 8A, issn 0002-9149, 36B-43B, SUPArticle